Statistical analysis of Goal Attainment Scaling endpoints in randomised trials.
Goal attainment scaling
categorical data
mixed effects model
patient involvement
small heterogeneous populations
Journal
Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
21
6
2018
medline:
28
7
2020
entrez:
21
6
2018
Statut:
ppublish
Résumé
Goal Attainment Scaling is an assessment instrument to evaluate interventions on the basis of individual, patient-specific goals. The attainment of these goals is mapped in a pre-specified way to attainment levels on an ordinal scale, which is common to all goals. This approach is patient-centred and allows one to integrate the outcomes of patients with very heterogeneous symptoms. The latter is of particular importance in clinical trials in rare diseases because it enables larger sample sizes by including a broader patient population. In this paper, we focus on the statistical analysis of Goal Attainment Scaling outcomes for the comparison of two treatments in randomised clinical trials. Building on a general statistical model, we investigate the properties of different hypothesis testing approaches. Additionally, we propose a latent variable approach to generate Goal Attainment Scaling data in a simulation study, to assess the impact of model parameters such as the number of goals per patient and their correlation, the choice of discretisation thresholds and the type of design (parallel group or cross-over). Based on our findings, we give recommendations for the design of clinical trials with a Goal Attainment Scaling endpoint. Furthermore, we discuss an application of Goal Attainment Scaling in a clinical trial in mastocytosis.
Identifiants
pubmed: 29921167
doi: 10.1177/0962280218777896
pmc: PMC6566461
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1893-1910Références
J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):500-7
pubmed: 12397141
PLoS One. 2008 May 28;3(5):e2266
pubmed: 18509466
Clin Rehabil. 2006 Sep;20(9):756-72
pubmed: 17005500
Am J Occup Ther. 1993 Apr;47(4):349-54
pubmed: 8322875
Dement Geriatr Cogn Disord. 2008;26(6):528-40
pubmed: 19052453
JAMA. 2003 May 21;289(19):2554-9
pubmed: 12759327
Res Social Adm Pharm. 2012 Mar-Apr;8(2):102-21
pubmed: 21454137
Arch Phys Med Rehabil. 2016 Jan;97(1):157-70
pubmed: 26343173
Stat Med. 2014 Nov 30;33(27):4734-42
pubmed: 25156155
Muscle Nerve. 2010 Apr;41(4):500-10
pubmed: 19941337
Phys Ther. 1993 Oct;73(10):651-8; discussion 658-60
pubmed: 7690976
J Am Med Dir Assoc. 2012 Jun;13(5):477-84
pubmed: 22521630
J Autism Dev Disord. 2012 Sep;42(9):1974-83
pubmed: 22271197
Dev Med Child Neurol. 2007 Nov;49(11):823-9
pubmed: 17979860
Community Ment Health J. 1968 Dec;4(6):443-53
pubmed: 24185570
BMC Med Res Methodol. 2016 Aug 17;16:99
pubmed: 27534620
J Clin Epidemiol. 1993 Oct;46(10):1113-8
pubmed: 8410096
Muscle Nerve. 2013 Sep;48(3):357-68
pubmed: 23674289
Ann Neurol. 2008 Jan;63(1):35-9
pubmed: 17886296
Dev Med Child Neurol. 2007 Jul;49(7):550-6
pubmed: 17593130
Stat Med. 1995 Jul 15;14(13):1491-504
pubmed: 7481187
Dev Med Child Neurol. 2006 Mar;48(3):170-5
pubmed: 16483391
J Rehabil Med. 2009 Jun;41(7):528-35
pubmed: 19543663
Dev Med Child Neurol. 2013 Nov;55(11):1038-45
pubmed: 23902233